Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Influenza, Human 1Hematologic Neoplasms 1

Interventions

Influenza Vaccines 2thymoglobulin 1peginterferon alfa-2a 1fludarabine 1baloxavir 1SARS-CoV-2 inactivated vaccines 1Rituximab 1Oseltamivir 1Melphalan 1Levetiracetam 1Lenalidomide 1Interferons 1Interferon alpha-2 1Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Influenza, Human × baloxavir × Other hematologic neoplasm × Clear all
NCT04712539 2026-02-11

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

M.D. Anderson Cancer Center

Phase 2 Recruiting
60 enrolled
Other hematologic neoplasm

Influenza, Human, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡